Apertum · Phase I in glioblastoma
What if more of a cancer drug could reach the brain?
Glioblastoma is a devastating, aggressive brain cancer. Even with surgery, radiation, and chemotherapy, it remains extraordinarily difficult to treat. Drug delivery is one major obstacle: the blood–brain barrier limits how much of many anticancer drugs can reach the brain.
We are working on a Phase I study of Apertum in glioblastoma, motivated by the potential to increase chemotherapy exposure in the brain. Getting more treatment where it is needed could open new possibilities. This early study starts with safety and feasibility; whether improved delivery leads to better outcomes remains a question for clinical research.
Background reading














